Biogen/Ionis’ Tofersen: US FDA Considering Both Accelerated And Regular Approval In ALS

 
• By Sue Sutter
Two apples on table
Two approval scenarios are on the table for tofersen. • Source: Shutterstock

More from US FDA Performance Tracker

More from Regulatory Trackers